NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 13, 2025 $34.80 +3.69% $33.91 V 97.38% 1
Oct 13, 2025 Bullish $33.91 V 1
Sep 29, 2025 $26.90 +5.20% $25.81 V 95.78% 1
Sep 26, 2025 $26.90 +7.21% $25.57 V 94.80% 1
Sep 25, 2025 $31.53 +18.40% $25.09 X 74.33% 0
Sep 24, 2025 $24.24 -2.91% $26.63 X 91.03% 0
Sep 24, 2025 $24.52 -1.82% $26.63 X 92.06% 0
Sep 24, 2025 $26.77 +7.21% $26.63 V 99.47% 4
Sep 23, 2025 Bullish $24.97 X 0
Sep 23, 2025 $25.52 -2.79% $24.97 V 97.81% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE